Home > News > Tech venture capital investments in decline
July 9th, 2007
Tech venture capital investments in decline
The biggest growth has been in the drug delivery and medical devices market where nine firms raised €17.4m, up from zero last year.
In the telecoms sector five companies raised €16.4m. This compares to six telecoms firms raising €21.1m in 2006. 17 other technology firms, including nanotechnology, raised €28.8m.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014
Thinnest feasible membrane produced April 17th, 2014
More effective kidney stone treatment, from the macroscopic to the nanoscale April 17th, 2014
High-temperature plasmonics eyed for solar, computer innovation April 17th, 2014